Stockscreener 앱 받기
0.5258
7.96%
-0.0455
전일 마감가:
$0.5713
열려 있는:
$0.58
하루 거래량:
350.33K
Relative Volume:
0.45
시가총액:
$46.80M
수익:
$38.70M
순이익/손실:
$-117.88M
주가수익비율:
-0.3093
EPS:
-1.7
순현금흐름:
$-92.84M
1주 성능:
+17.60%
1개월 성능:
-32.36%
6개월 성능:
-64.47%
1년 성능:
-76.84%
1일 변동 폭
$0.5229
$0.6099
1주일 범위
$0.47
$0.61
52주 변동 폭
$0.4471
$2.29
Adicet Bio Inc Stock (ACET) Company Profile
명칭
Adicet Bio Inc
전화
617-482-2333
주소
131 DARTMOUTH STREET, BOSTON
ACET을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACET
Adicet Bio Inc
|
0.5258 | 46.80M | 38.70M | -117.88M | -92.84M | -1.70 |
|
VRTX
Vertex Pharmaceuticals Inc
|
489.10 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.16 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
596.20 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
234.56 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
230.98 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Adicet Bio Inc Stock (ACET) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-30 | 재개 | Guggenheim | Buy |
| 2024-09-11 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2023-06-27 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2023-06-01 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2022-09-21 | 개시 | JP Morgan | Overweight |
| 2022-03-31 | 개시 | SMBC Nikko | Outperform |
| 2022-03-08 | 개시 | Truist | Buy |
| 2022-03-04 | 개시 | Jefferies | Buy |
| 2021-05-18 | 개시 | BTIG Research | Buy |
| 2021-04-23 | 개시 | H.C. Wainwright | Buy |
| 2021-04-14 | 개시 | Canaccord Genuity | Buy |
| 2021-04-08 | 개시 | Guggenheim | Buy |
| 2020-11-04 | 개시 | B. Riley Securities | Buy |
| 2020-10-27 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-16 | 개시 | Wedbush | Outperform |
모두보기
Adicet Bio Inc 주식(ACET)의 최신 뉴스
Adicet Bio (NASDAQ:ACET) Now Covered by StockNews.com - Defense World
Adicet Bio appoints Michael Grissinger to its board By Investing.com - Investing.com Canada
Adicet Bio Appoints Michael Grissinger to the Board of Directors - BioSpace
Adicet Bio appoints Michael Grissinger to its board - Investing.com
Adicet Bio Appoints Michael Grissinger to Board - TipRanks
Adicet Bio Appoints Michael Grissinger To The Board Of Directors - marketscreener.com
Adicet Bio Strengthens Board with Ex-Johnson & Johnson VP: Strategic Move for Cell Therapy Pioneer - Stock Titan
Norges Bank Acquires Shares of 429,550 Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio faces potential Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Adicet Bio faces potential Nasdaq delisting over share price - Investing.com
Virtu Financial LLC Purchases New Stake in Adicet Bio, Inc. (NASDAQ:ACET) - Defense World
Adicet Bio to Participate in 2025 Canaccord Genuity Horizons in Oncology Virtual Conference - BioSpace
Adicet Bio Strengthens Team with Strategic Stock Options Package for Key New Hires - Stock Titan
Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Consensus Target Price from Brokerages - Defense World
The Royal Office of H.H. Sheikh Ahmed Bin Faisal Al-Qassimi and ACET ($ACT) Drive Blockchain Payment Innovation in UAE’s $3.9 Billion USD Initiative - GlobeNewswire Inc.
Adicet Bio (NASDAQ:ACET) Earns “Buy” Rating from Guggenheim - The AM Reporter
Adicet Bio (ACET): Among the Penny Stocks With Huge Upside Potential According to Analysts - Insider Monkey
Guggenheim Reiterates Buy Rating for Adicet Bio (NASDAQ:ACET) - Defense World
10 Penny Stocks With Huge Upside Potential According To Analysts - Insider Monkey
ACET Stock Dips to 52-Week Low at $0.74 Amid Market Challenges - Investing.com
Short Interest in Adicet Bio, Inc. (NASDAQ:ACET) Drops By 16.9% - Defense World
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4) - Business Wire
Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year - Investing.com Canada
Adicet Bio’s SWOT analysis: gamma-delta T cell stock faces pivotal year By Investing.com - Investing.com South Africa
Adicet Bio (ACET) Expected to Announce Earnings on Tuesday - Defense World
Promising Pipeline and Strong Financials Drive Buy Rating for Adicet Bio - TipRanks
Adicet Bio (NASDAQ:ACET) Earns “Neutral” Rating from HC Wainwright - Defense World
Adicet Bio Advances Clinical Trials and Financial Stability - TipRanks
H.C. Wainwright maintains Neutral on Adicet Bio stock By Investing.com - Investing.com South Africa
H.C. Wainwright maintains Neutral on Adicet Bio stock - Investing.com India
Cautious Hold Rating on Adicet Bio Amid Early-Stage Clinical Developments and Uncertain Outcomes - TipRanks
Adicet Bio: Hold Rating Amid Fair Valuation and Awaited Clinical Data - TipRanks
Adicet Bio Inc Files For Mixed Shelf Of Up To $250 Million -March 06, 2025 at 04:59 pm EST - Marketscreener.com
Adicet Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Highlights Recent Company Progress - Lelezard
Adicet Bio, Inc Q4 Loss Decreases - Nasdaq
Adicet Bio reports Q4 EPS (32c), consensus (35c) - TipRanks
Can Adicet Bio's $176M War Chest and Fast Track Status Transform Autoimmune Treatment? - StockTitan
Adicet Bio, Inc. (NASDAQ:ACET) Receives $7.50 Average Target Price from Analysts - Defense World
Adicet Bio, Inc. (NASDAQ:ACET) Short Interest Update - Defense World
Adicet Announces Poster Presentations Highlighting ADI-270 Data at the Society for Immunotherapy of Cancer (SITC) 2025 Spring Scientific Meeting - BioSpace
Adicet Bio Inc (ACET) 재무 분석
매출
순이익
현금흐름
주당 순 이익
2.51%
자본화:
|
볼륨(24시간):